Metoprolol-Z Retard Al

Metoprolol tartrate, the active ingredient in Metoprolol‑Z Retard Al, is a beta‑adrenergic blocking agent presented as an oral tablet for oral use. It lowers blood pressure, relieves angina and supports heart‑failure management in adult patients.

GNH USA supplies Metoprolol‑Z Retard Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol tartrate is used to manage cardiovascular conditions that involve excessive sympathetic stimulation. - Hypertension: lowers systolic and diastolic pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Post‑myocardial infarction: improves survival by limiting arrhythmias and remodeling. - Chronic heart failure: enhances ventricular function and reduces hospitalisation risk. - Certain cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other supraventricular tachyarrhythmias.

Metoprolol tartrate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Gastrointestinal discomfort such as nausea or abdominal pain

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm in patients with reactive airway disease - Allergic reactions including rash or angioedema - Depression or mood changes

Metoprolol tartrate requires careful monitoring in several clinical situations. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess heart rate: ensure rate does not fall below safe limits. - Use caution in asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully prevent bronchospasm. - Avoid abrupt discontinuation: taper dose to prevent rebound tachycardia or hypertension. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Metoprolol tartrate can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): may cause severe heart block.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may mask hypoglycaemia symptoms. - NSAIDs: can reduce antihypertensive effect. - Antidepressants (e.g., SSRIs): may increase plasma metoprolol levels.